why choose us

First received: January 16, 2023

Clinical Trial: Effect of Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Prenatal Depression
Ketamine
Postpartum Depression

Study Type: Interventional


Official Title: Effect of Intravenous Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth in Women With Prenatal Depression: 2-year Follow-up of a Randomized Controlled Trial

Brief Summary: Postpartum depression refers to the depression after childbirth, which is a common mental disorder in women. The pathogenesis of postpartum depression is not fully understood, and may be related to a variety of factors. Prenatal depression is an important risk factor for postpartum depression. Our recent multicenter randomized controlled trial, "Effect of Low-dose esketamine on the incidence of postpartum depression in women with prenatal depression", explored the effect of immediate postpartum intravenous…

Read more